Clinical trials
Completed Myocardial Ischemia trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Meshalkin Research Institute of Pathology of Circulation | 4 |
| Eurasian Association of Therapists | 2 |
| I.M. Sechenov First Moscow State Medical University | 2 |
| St. Petersburg State Pavlov Medical University | 2 |
| AO GENERIUM | 1 |
| Abbott Medical Devices | 1 |
| Amarin Pharma Inc. | 1 |
| Cytokinetics | 1 |
| Federal State Budgetary Institution "Federal Center for Cardiovascular Surgery named after S.G. Sukh | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Ischemia | 19 |
| Coronary Artery Disease | 10 |
| Coronary Stenosis | 4 |
| Myocardial Infarction | 4 |
| Angina Pectoris | 3 |
| Cardiovascular Diseases | 3 |
| Coronary Disease | 3 |
| Heart Diseases | 3 |
| Acute Coronary Syndrome | 2 |
| Angina, Unstable | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.